Impact of COVID-19 on Telehealth.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 7, p. 17
- Publication type:
- Article
Works matching IS 21644403 AND DT 2020 AND VI 10 AND IP 7
Results: 24
1
2
Opdivo plus Yervoy and Chemotherapy Approved as First-Line Therapy for Metastatic NSCLC Regardless of PD-L1 Expression.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 7, p. 46
- Publication type:
- Article
3
Tecentriq plus Avastin First Immunotherapy Regimen Approved for Metastatic Hepatocellular Carcinoma.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 7, p. 45
- Publication type:
- Article
4
FDA Approves Cyramza plus Tarceva for First-Line Treatment of Metastatic NSCLC with EGFR Mutation.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 7, p. 44
- Publication type:
- Article
5
Zepzelca New Therapy Approved for Metastatic Small-Cell Lung Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 7, p. 42
- Publication type:
- Article
6
Opdivo Approved for Advanced Esophageal Squamous-Cell Carcinoma.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 7, p. 44
- Publication type:
- Article
7
FDA Approves Bavencio as First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 7, p. 42
- Publication type:
- Article
8
Chemoimmunotherapy Combo Shows Efficacy in Patients with Advanced Urothelial Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 7, p. 40
- By:
- Publication type:
- Article
9
Enfortumab Vedotin plus Pembrolizumab Combination Leads to Impressive Responses in Patients with Urothelial Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 7, p. 38
- By:
- Publication type:
- Article
10
Melflufen plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: The HORIZON Trial.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 7, p. 35
- Publication type:
- Article
11
Most Patients on SBRT for Localized Prostate Cancer Do Not Receive Concurrent ADT, Despite NCCN Guidelines.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 7, p. 36
- By:
- Publication type:
- Article
12
Comparison of MRD Status in Newly Diagnosed Transplant-Eligible Patients with Multiple Myeloma: The FORTE Trial.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 7, p. 34
- Publication type:
- Article
13
Isatuximab plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma: The IKEMA Trial.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 7, p. 34
- Publication type:
- Article
14
ctDNA Alterations Correlate with Survival in Patients with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 7, p. 33
- By:
- Publication type:
- Article
15
Pembrolizumab plus Enzalutamide Shows Activity in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 7, p. 32
- By:
- Publication type:
- Article
16
Surgery Is a Viable Treatment Option for Patients with Early-Stage Germ Cell Tumors.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 7, p. 30
- By:
- Publication type:
- Article
17
What's New in Lung Cancer Immunotherapy?
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 7, p. 28
- By:
- Publication type:
- Article
18
Medically Integrated Pharmacy Care Improves Patient Satisfaction and Outcomes.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 7, p. 25
- By:
- Publication type:
- Article
19
Atezolizumab, Vemurafenib, and Cobimetinib Triplet Therapy Improves PFS in BRAF-Positive Melanoma.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 7, p. 16
- By:
- Publication type:
- Article
20
Immune Checkpoint Inhibitor Does Not Improve Outcomes in Metastatic Prostate Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 7, p. 13
- By:
- Publication type:
- Article
21
Two Ways to Target Tumors with KRAS Mutations.
- Published in:
- 2020
- By:
- Publication type:
- Proceeding
22
Adapting to the "New Normal" in Community Oncology.
- Published in:
- 2020
- By:
- Publication type:
- Proceeding
23
Why Is COVID-19 More Aggressive in Certain Patients with Cancer?
- Published in:
- 2020
- By:
- Publication type:
- Proceeding
24
Early Detection of Cancer Feasible with Blood-Based Tests.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 7, p. 1
- By:
- Publication type:
- Article